Emerging concepts in heart failure management and treatment: focus on vericiguat
The nitric oxide (NO)–soluble guanylate cyclase (sGC)– cyclic guanosine monophosphate (cGMP) pathway is dysregulated in patients with heart failure (HF) resulting in myocardial and vascular dysfunction that contributes to its progression. Vericiguat is a novel direct sGC stimulator that targets in a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2023-01-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/emerging-concepts-in-heart-failure-management-and-treatment-focus-on-vericiguat |